YY1 and prostate cancer: The expression of YY1 was upregulated in many cancers, which might play a regulatory role in the activation, progression, and/or maintenance of malignant tumors in many tumor models and was associated with poor prognosis [40], including breast cancer, pancreatic cancer, prostate cancer [41], and colon cancer [42].